Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,647 | 203 | 90.5% |
| Travel and Lodging | $802.80 | 2 | 9.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| BIOTISSUE HOLDINGS INC. | $1,916 | 19 | $0 (2024) |
| Bausch & Lomb Americas Inc. | $914.66 | 27 | $0 (2024) |
| Alcon Vision LLC | $857.33 | 19 | $0 (2024) |
| NEW WORLD MEDICAL,INC. | $730.97 | 9 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $526.14 | 21 | $0 (2023) |
| ABBVIE INC. | $355.67 | 11 | $0 (2024) |
| Johnson & Johnson Surgical Vision, Inc. | $338.00 | 9 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $321.32 | 17 | $0 (2024) |
| Alcon Laboratories Inc | $301.81 | 4 | $0 (2018) |
| Oyster Point Pharma, Inc. | $293.78 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,889 | 55 | Bausch & Lomb Americas Inc. ($582.04) |
| 2023 | $3,150 | 62 | BIOTISSUE HOLDINGS, INC. ($1,560) |
| 2022 | $589.37 | 24 | Alcon Vision LLC ($179.33) |
| 2021 | $628.51 | 16 | Akorn Operating Company LLC ($187.04) |
| 2020 | $554.71 | 16 | Johnson & Johnson Surgical Vision, Inc. ($167.13) |
| 2019 | $507.55 | 10 | NEW WORLD MEDICAL,INC. ($236.03) |
| 2018 | $645.61 | 11 | Alcon Laboratories Inc ($224.90) |
| 2017 | $484.92 | 11 | Valeant Pharmaceuticals North America LLC ($156.65) |
All Payment Transactions
205 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $23.69 | General |
| Category: EYE CARE | ||||||
| 12/18/2024 | Alcon Vision LLC | Clareon (Device) | Food and Beverage | In-kind items and services | $25.85 | General |
| Category: Ophthalmology | ||||||
| 12/18/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $22.75 | General |
| Category: Ophthalmology | ||||||
| 12/14/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $6.07 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 12/13/2024 | Harrow Eye, LLC | VEVYE (Drug) | Food and Beverage | In-kind items and services | $24.96 | General |
| Category: OPTOMETRY | ||||||
| 12/05/2024 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: SOLUTION/ DROPS | ||||||
| 12/04/2024 | Alcon Vision LLC | Clareon (Device) | Food and Beverage | In-kind items and services | $6.59 | General |
| Category: Ophthalmology | ||||||
| 11/22/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $34.93 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 11/19/2024 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $28.97 | General |
| Category: SOLUTION/ DROPS | ||||||
| 11/09/2024 | Alcon Vision LLC | ARGOS (Device) | Food and Beverage | In-kind items and services | $116.19 | General |
| Category: Ophthalmology | ||||||
| 11/04/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $21.19 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 10/23/2024 | Alcon Vision LLC | Clareon (Device) | Food and Beverage | In-kind items and services | $9.66 | General |
| Category: Ophthalmology | ||||||
| 10/10/2024 | ABBVIE INC. | XEN GLAUCOMA TREATMENT SYSTEM (Device) | Food and Beverage | In-kind items and services | $142.07 | General |
| Category: EYE CARE | ||||||
| 10/08/2024 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $22.91 | General |
| Category: SOLUTION/ DROPS | ||||||
| 09/30/2024 | Harrow Eye, LLC | VEVYE (Drug) | Food and Beverage | In-kind items and services | $22.60 | General |
| Category: OPTOMETRY | ||||||
| 09/26/2024 | Bausch & Lomb Americas Inc. | enVista MX60 IOL (Device) | Food and Beverage | In-kind items and services | $28.73 | General |
| Category: Ophthalmology | ||||||
| 09/17/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $34.65 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 08/19/2024 | Bausch & Lomb Americas Inc. | enVista MX60 IOL (Device) | Food and Beverage | In-kind items and services | $26.78 | General |
| Category: Ophthalmology | ||||||
| 08/06/2024 | Harrow Eye, LLC | VEVYE (Drug) | Food and Beverage | In-kind items and services | $22.39 | General |
| Category: OPTOMETRY | ||||||
| 08/05/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | Cash or cash equivalent | $149.13 | General |
| 07/24/2024 | Bausch & Lomb Americas Inc. | enVista MX60 IOL (Device) | Food and Beverage | In-kind items and services | $106.65 | General |
| Category: Ophthalmology | ||||||
| 07/24/2024 | Bausch & Lomb Americas Inc. | enVista MX60 IOL (Device) | Food and Beverage | In-kind items and services | $23.40 | General |
| Category: Ophthalmology | ||||||
| 07/24/2024 | Bausch & Lomb Americas Inc. | enVista MX60 IOL (Device) | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: Ophthalmology | ||||||
| 07/23/2024 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $23.71 | General |
| Category: SOLUTION/ DROPS | ||||||
| 07/15/2024 | Harrow Eye, LLC | VEVYE (Drug) | Food and Beverage | In-kind items and services | $21.52 | General |
| Category: OPTOMETRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 2,532 | 3,545 | $1.3M | $376,553 |
| 2022 | 24 | 2,875 | 3,945 | $1.4M | $428,933 |
| 2021 | 24 | 2,726 | 3,536 | $1.5M | $434,072 |
| 2020 | 28 | 3,451 | 4,126 | $1.4M | $388,440 |
All Medicare Procedures & Services
97 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2023 | 115 | 151 | $302,000 | $70,942 | 23.5% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 505 | 588 | $117,600 | $59,670 | 50.7% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 15 | 58 | $116,000 | $40,202 | 34.7% |
| 68761 | Closure of tear duct opening using plug | Office | 2023 | 123 | 410 | $82,000 | $37,506 | 45.7% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 307 | 416 | $83,200 | $31,132 | 37.4% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 218 | 218 | $65,400 | $24,556 | 37.5% |
| 67040 | Destruction of eye fluid (vitreous) between lens and retina and all of retina using a laser | Facility | 2023 | 22 | 22 | $66,000 | $19,021 | 28.8% |
| 67210 | Destruction of growth of retina using a laser | Office | 2023 | 31 | 35 | $52,500 | $15,631 | 29.8% |
| 67028 | Injection of drug into eye | Office | 2023 | 74 | 144 | $95,250 | $14,046 | 14.7% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Office | 2023 | 44 | 46 | $69,000 | $13,995 | 20.3% |
| 92250 | Photography of the retina | Office | 2023 | 337 | 347 | $52,050 | $10,624 | 20.4% |
| 92134 | Imaging of retina | Office | 2023 | 182 | 288 | $43,200 | $10,148 | 23.5% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 157 | 162 | $32,400 | $8,885 | 27.4% |
| 67228 | Destruction of leaking blood vessels of retina using laser | Office | 2023 | 18 | 23 | $34,500 | $6,826 | 19.8% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2023 | 53 | 77 | $11,550 | $4,379 | 37.9% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2023 | 111 | 112 | $33,400 | $4,281 | 12.8% |
| 92133 | Imaging of optic nerve | Office | 2023 | 100 | 102 | $15,300 | $3,123 | 20.4% |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | Office | 2023 | 64 | 66 | $6,600 | $855.22 | 13.0% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2023 | 14 | 14 | $1,400 | $291.59 | 20.8% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2023 | 24 | 24 | $1,440 | $235.91 | 16.4% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 18 | 242 | $2,690 | $203.95 | 7.6% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 581 | 663 | $132,600 | $69,484 | 52.4% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2022 | 102 | 130 | $260,000 | $61,930 | 23.8% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 16 | 74 | $148,000 | $53,211 | 36.0% |
| 68761 | Closure of tear duct opening using plug | Office | 2022 | 135 | 411 | $82,200 | $39,138 | 47.6% |
About Dr. Robert Feig, MD
Dr. Robert Feig, MD is a Ophthalmology healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1669441101.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Feig, MD has received a total of $8,450 in payments from pharmaceutical and medical device companies, with $1,889 received in 2024. These payments were reported across 205 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($7,647).
As a Medicare-enrolled provider, Feig has provided services to 11,584 Medicare beneficiaries, totaling 15,152 services with total Medicare billing of $1.6M. Data is available for 4 years (2020–2023), covering 97 distinct procedure/service records.
Practice Information
- Specialty Ophthalmology
- Other Specialties Ophthalmology
- Location Brooklyn, NY
- Active Since 03/16/2006
- Last Updated 07/16/2024
- Taxonomy Code 207W00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1669441101
Products in Payments
- Ahmed Glaucoma Valve (Device) $730.97
- enVista MX60 IOL (Device) $659.59
- PROKERA (Device) $451.75
- ARGOS (Device) $436.94
- XIIDRA (Drug) $328.60
- Cequa (Drug) $303.23
- TYRVAYA (Drug) $293.78
- AcrySof (Device) $268.44
- Vabysmo (Drug) $250.53
- LUMIGAN (Drug) $237.04
- Tecnis 1-piece IOL (Device) $208.13
- Zioptan (Drug) $187.04
- VEVYE (Drug) $160.00
- PROLENSA (Drug) $143.06
- XEN GLAUCOMA TREATMENT SYSTEM (Device) $142.07
- Flarex (Drug) $136.37
- AcrySof IQ VIVITY (Device) $136.17
- XDEMVY (Drug) $135.23
- MIEBO (Drug) $125.00
- Hydrus Microstent (Device) $124.37
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Brooklyn
David Rubaltelli, M.d, M.D
Ophthalmology — Payments: $8.9M
Dr. Irene Gladstein, M.d, M.D
Ophthalmology — Payments: $106,815
Mr. Raphael Rosenbaum, M.d, M.D
Ophthalmology — Payments: $40,149
Dr. Leonard Bley, M.d, M.D
Ophthalmology — Payments: $23,405
Dr. Bradley Phillips, M.d, M.D
Ophthalmology — Payments: $16,804
Joseph Zelefsky, Md, MD
Ophthalmology — Payments: $12,170